Analyst Price Target is $1.00
▲ +23.46% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for PolarityTE in the last 3 months. The average price target is $1.00, with a high forecast of $1.00 and a low forecast of $1.00. The average price target represents a 23.46% upside from the last price of $0.81.
Current Consensus is
The current consensus among 2 polled investment analysts is to buy stock in PolarityTE. This rating has held steady since December 2022, when it changed from a Hold consensus rating.
PolarityTE, Inc. is a biotechnology company developing and commercializing regenerative tissue products and biomaterials. The firm products include SkinTE Cryo, SkinTE POC, PTE 11000, OsteoTE and Real Time Assistant. Its SkinTE product is commercially available for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. The firm operates through the following segments: regenerative medicine products and contract services. PolarityTE was founded on May 8, 1998 and is headquartered in Salt Lake City, UT.